A simple test could extend cystic-fibrosis treatments to those left behind

Sweat-chloride measurements could be used to develop and approve drugs for rare mutations in cystic fibrosis. Sweat-chloride measurements could be used to develop and approve drugs for rare mutations in cystic fibrosis.

Saved in:
Bibliographic Details
Published in:Nature (London) 2020-07, Vol.583 (7818), p.S5-S5
Main Author: Rowe, Steven M.
Format: Article
Language:English
Subjects:
631/154
692/699
692/700
692/700/565
Cystic fibrosis
Dosage and administration
Drug therapy
Gene mutations
Ivacaftor
Laws, regulations and rules
n/a
Outlook
Statistics
Testing
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Sweat-chloride measurements could be used to develop and approve drugs for rare mutations in cystic fibrosis. Sweat-chloride measurements could be used to develop and approve drugs for rare mutations in cystic fibrosis.
ISSN:0028-0836
1476-4687
DOI:10.1038/d41586-020-02107-9